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In this paper we describe the microcomputer-aided de- 
termination of cell proliferation kinetics and doubling 
times utilizing a crystal violet assay and a 3-(4,5-dimeth- 
ylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide 
assay in microtitration plates. The analysis of spectro- 
photometric data provides the doubling times at any 
time of incubation. Plots of doubling time versus time of 
incubation give reproducible information on the exact 
duration of the logarithmic growth phase. This method 
is applicable to anchorage-dependent as well as anchor- 
age-independent cells when calorimetric or fluoromet- 
ric data are accessible. o isso Academic press, h. 
A great problem in the testing of new anticancer drugs 
by the cell culture technique is the marked genetic insta- 
bility of tumor cells (1,2) entailing an extreme clonal 
variation (3). This becomes evident with growing num- 
bers of passages from a permanent change of parameters 
of cell proliferation like the duration of the lag phase and 
of the log period, the doubling time, and the saturation 
density (plateau level). For example, Reddel et al. (4) ob- 
served such a perpetual decrease of doubling time in sub- 
cultures of the human breast cancer cell line T-47-D. 
Since drugs can show quite different inhibitory effects 
dependent of the growth parameters of a given tumor 
cell line, the knowledge of the growth parameters in each 
test series is of importance for the experimental repro- 
ducibility. Although it is generally postulated that the 
exposure of the tumor cells to the drug should occur in 
the phase of exponential growth, this demand often does 
not meet experimental verification. 
Conventionally, mean doubling times are determined 
graphically from the mid log phase or calculated from 
initial and final cell numbers (5) counted with either a 
hemocytometer or an electronic particle counter which 
requires removing the cells from their substratum. Ei- 
ther method could lead to severe misinterpretation due 
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to practical difficulties in distinguishing the lag phase 
from the phase of exponential growth. 
In this publication we describe a microcomputer tech- 
nique which allows the registration of growth curves of 
cells in monolayer cultures by large scale spectrophoto- 
metric measurement after crystal violet staining’ (6) or 
MTT incorporation (7-9) using 96-well microtitration 
plates. This method enables the overall growth curve es- 
pecially the lag phase and the log period to be deter- 
mined in a more exact way. As a consequence it is also 
possible to precisely assess the doubling time (TAU) at 
any time of the experiment. In our opinion a plot of TAU 
versus time (t) provides the maximum information 
available from cell proliferation experiments. 
METHODS 
Chemicals. Reagents (A-grade purity) were obtained 
from Merck. Crystal violet and MTT were purchased 
from Serva; dimethyl sulfoxide (DMSO) spectrophoto- 
metric grade was obtained from Aldrich. Millipore-fil- 
tered water was used throughout. 
Cell lines and culture conditions. MDA-MB-231 
(ATCC No. HTB 26), a human adenocarcinoma of the 
breast, was maintained in McCoy’s 5A medium (Boehr- 
inger) containing L-glutamine, NaHCO, (2.3 g/liter), 
gentamycin (50 mg/liter), and 10% NCS (GIBCO) in 75 
cm2 flasks (Falcon Plastics 3023) as a monolayer. 
The cells were serially passaged weekly following tryp- 
sinization using trypsin/EDTA (Boehringer). 
P388DI (ATCC No. CCL 46), a murine lymphoid neo- 
plasm, was grown in a suspension culture in Dulbecco’s 
modified Eagle’s medium (Seromed) containing glucose 
’ Abbreviations used: crystal violet, N-hexamethylpararosaniline; 
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2~-tetrazolium bro- 
mide; DMSO, dimethyl sulfoxide; PBS, phosphate-buffered saline; 
OD, optical density; PC, personal computer; NCS, newborn calf se- 
rum. 
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FLOW CHART 1. Registration of growth curves using the crystal 
violet dye procedure. Optical density reading at 578 nm gives improved 
sensitivity and reliability. 
(4.5 g/liter), NaHCO, (3.7 g/liter), sodium pyruvate (110 
mg/liter), gentamycin (50 mg/liter), and 10% horse se- 
rum (Boehringer) in 75cm2 culture flasks. The cells 
were passaged every 3-4 days by 1:40 dilution with fresh 
medium. 
Both cell lines were grown at 37°C in a humidified at- 
mosphere of 95% air and 5% carbon dioxide. 
Mycoplasma contamination was monitored by routine 
assay techniques (Hoechst 33.258) (lo), and only my- 
coplasma-free cultures were used. 
Registration of growth curves. The assay was carried 
out in flat-bottomed microtitration trays (Falcon Plas- 
tics 3075). Optical density was read using a Biotek EL 
309 Autoreader (Tecnomara) at 578 nm (crystal violet) 
and 540 nm (MTT). 
(I) MDA-MB-231 cells were processed as shown in 
Flow Chart 1 by modifying the crystal violet staining 
procedure described by Gillies et al. (6). 
(II) The proliferation of P388D1 cells was quantitated 
according to a microculture modification of the tetrazo- 
lium assay (7-9, 11): MTT was prepared as a 1 mg/ml 
stock solution in medium and filtered through a 0.22-pm 
filter to remove undissolved dye. At the times indicated 
in Fig. 1, 50 ~1 of stock MTT solution was added to all 
wells, each containing 100 ~1 of cell suspension. The 
plates were gently shaken and incubated at 37°C for an- 
other 1.5 h. Supernatant removal was accomplished by 
carefully inverting and blotting the tray; no prior cen- 
trifugation was needed, since the macrophage-like cells 
sedimented and adhered to the substratum. One hun- 
dred microliters of DMSO was added to all wells to dis- 
solve the formazan crystals. 
Cytogenetic analysis. The cells were grown to about 
50% confluence on microscopic slides. The slides were 
prepared as described elsewhere (12). So that spindle 
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FLOW CHART 2. Analysis of spectrophotometric data. 
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FIG. 1. (A) Calorimetric measurement of growth in microtitration plates. (0) P388D1 leukemia cells from passage 28 (original passage 
unknown, numbered upon receipt from the ATCC) were seeded at a density of 8 X 10’ cells/ml (Coulter Counter ZsI). At the times indicated, 
MTT was added to all wells, and after another 1.5 h the plates were developed and read immediately at 540 nm. (@) The human breast cancer 
cell line MDA-MB-231 was plated in the 38th passage from origin at a density of 12 cells per field of vision. The cells were seeded in 100 ~1 
medium/well and were allowed to attach. Cell densities were estimated by counting 50 fields of vision using a Leitz Diavert phase-contrast 
microscope (320X). At the times indicated, the cells were fixed with 1% glutaraldehyde in PBS for 15 min and stored under PBS at 4°C. At the 
end of the experiment all trays were stained with crystal violet simultaneously. OD was measured after extraction of the dye with 70% ethanol 
at 578 nm. (B) Plots of the corresponding doubling times, calculated from the data shown in A, versus time of incubation. 
formation could be inhibited, the slide chambers were 
inoculated with Colcemid solution (Serva) to a final con- 
centration of 0.04 pg/ml and incubated for 3 h at 37°C. 
The medium was removed by suction and replaced with 
0.075 M KCl. After 30 min of incubation at 37°C an equal 
volume of cold, freshly made fixative (absolute metha- 
nol/glacial acetic acid, 3/l) was added. This hypotonic/ 
fixative mixture was removed immediately and replaced 
twice with ice-cold, fresh fixative. The slides were re- 
moved from the dish and air-dried. 
The chromosomes were stained for 8 min with 10 ml 
Giemsa plus 90 ml of 0.025 M KH,PO,, pH 6.8. 
observed. Once the polynomial fit has been performed 
the doubling time TAU can easily be calculated at any 
time of the interval concerned provided that exponential 
growth is observed (13), 
TAU = l/cu 
a! = l/in(2) .d ln(OD)/dt 
OD = C aiti, 
and hence 
Computer processing. Readings from the EL 309 au- 
toreader (Biotek) were transferred directly to an Olivetti 
TAU = ln(2).(C Uit”)/(C i*oit”-‘); (i = 0, 1, . . . , n). 
M24 personal computer, using a program that saved the 
OD values on a diskette. The program for data process- ABS (TAU) is plotted versus time. From this plot the 
ing is graphed in Flow Chart 2. time interval where exponential growth occurs and the 
Doubling time analysis. Curve fitting of experimental corresponding doubling time can easily be determined. 
data is accomplished by a polynomial regression fit ap- The software for evaluating cell kinetic data was devel- 
plying the least-squares method. Optical density is de- oped in FORTRAN and PASCAL and implemented on 
scribed as a function of time and data points are fitted an Olivetti M24 pc. 
to an nth order polynomial (usually n = 5) represented 
by RESULTS 
OD = f(t) = C Uiti; (i = 0, 1, . . . , n) 
Figure 1 illustrates the growth curves and the corre- 
sponding doubling times at any time of incubation for 
Ui = regression coefficients. an anchorage-dependent (MDA-MB-231) cell line and 
an anchorage-independent (P388D,) cell line. The 
This polynomial is defined in the time interval of points curves were registered using two different staining tech- 
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FIG. 2. Reproducibility of doubling time determination by the crys- 
tal violet assay. MDA-MB-231 cells were plated at an approximate 
density of 15 cells per field of vision (Leitz Diavert, 320X). The calcu- 
lated doubling times from four different experiments (all processed 
separately) are plotted versus time of incubation. 
niques: crystal violet for MDA-MB-231 and MTT for 
P388D1. Due to their macrophage-like properties (ten- 
dency to attach) no centrifugation step was required in 
the case of P388DI cells. A general application of the 
MTT procedure to anchorage-independent cells re- 
quires a centrifuge equipped with a rotor capable of ac- 
cepting multiplates. 
Under the given experimental conditions for both cell 
lines the logarithmic phase covers only a small fraction 
of the overall growth curve. In a plot, doubling time 
(TAU) versus time of incubation (t) (Fig. lB), exponen- 
tial growth is characterized by a parallelism of the 
graphs with the t-axis. Although in Fig. 1A the time 
points are not equidistant the calculated doubling times 
for the exponential growth phase are not significantly 
affected by closely spaced points at either end of the 
curve. A close scattering of data at both ends is required 
to separate the log phase from the lag and the plateau 
phases where cell proliferation becomes extremely slow 
resulting in infinite doubling times. Therefore only 
quantification of the log phase is of biological signifi- 
cance. 
MDA-MB-231 grows exponentially for about two gen- 
erations with a doubling time of -34 h, whereas the log 
phase for P388DI at the given plating density is re- 
stricted to one doubling of the population. 
By performing the doubling time calculations from 
four successive crystal violet processing procedures uti- 
lizing MDA-MB-231 cells in the same passage seeded at 
comparable plating densities, we encountered an inter- 
assay variation of ~13% (Fig. 2). 
The karyotype information presented in Fig. 3 gives 
an example for the dramatic variability of a well-defined 
cell line after prolonged culture in vitro following cryo- 
preservation. Genotypic changes do not only reflect phe- 
notypic characteristics like morphology, but may also al- 
ter cell physiology as well as cell proliferation, which 
directly affects doubling time (14). 
Figure 4 illustrates the alterations in doubling time as 
a result of the number of passages. The doubling times of 
MDA-MB-231 cells maintained under constant culture 
conditions decreased constantly with prolonged time in 
culture. In the crystal violet assay the cells were seeded 
at comparable densities. The doubling times vary enor- 
mously over a wide range from x10 h for a late (85th) to 
=38 h for a relatively early (35th) passage. The varia- 
tion most probably arises from the selection of faster 
growing subclones from an initially heterogeneous popu- 
lation by frequent and incomplete trypsinization of the 
culture. 
It is widely accepted that the initial cell number in- 
fluences the proliferation kinetics of eukaryotic cells. 
This marked influence on doubling time is shown in 
Fig. 5. 
DISCUSSION 
While a variety of techniques (6-10, 15) including an 
enzyme immunoassay for estimating small cell numbers 
(16) have been described recently for the determination 
of parameters for cell proliferation, little interest was fo- 
cused on the construction and analysis of growth curves 
in animal cell culture. 
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FIG. 3. Genetic instability of MDA-MB-231 cells. (Cl) 27th passage 
from origin, (H) 35th passage from origin: The cells were cryopreserved 
in passage 28 for about 6 months and then passaged weekly, when 
rethawed. For each passage the chromsomes from 50 well-spread 
metaphase plates were counted. 
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It has been common practice to assume that cells ex- 
hibit ideal exponential growth regardless of the diversi- 
ties of experimental designs without further verification. 
In our opinion the description of the overall growth 
characteristics with an exact determination of the lag/ 
log phases, the doubling time (TAU), and the plateau 
level is absolutely necessary. In addition to the char- 
acterization of cell lines (e.g., morphology, karyotype, 
receptor pattern, sensitivity to antitumor drugs) the de- 
scription of the exponential growth phase is a prerequi- 
site for any valuable experimental setup. Especially, the 
investigation of cell lines underlying extreme genetic 
variability, e.g., transformed cells and cancer cells, re- 
quires a precise description and verification of the pa- 
rameters concerned. Due to time-consuming and diffi- 
cult experimental procedures this is usually not 
performed. 
The major disadvantage of the methods described so 
far (5, 17, 18) is the production of mean values rather 
than exact values. Due to laborious working techniques 
only a few data points are generally obtained. This re- 
sults in poor graphical estimates which make the separa- 
tion of the lag/log/plateau phases of growth curves ex- 
tremely difficult and unsatisfactory. 
In this paper we describe a technique which offers a 
number of advantages compared with conventional 
methods. This inexpensive, rapid, and technically easy 
microtitration assay gives access to large sets of data 
thus providing results of high statistical significance. 
The equipment necessary (microplate reader, PC) is 
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FIG. 4. Doubling time as a function of passage using MDA-MB-231 
cells in the (0) 35th, (0) 39th, and (0, n ) 85th passage. (m) The cells 
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FIG. 5. Doubling time as a function of initial cell number. MDA- 
MB-231 cells were plated in passage 39 at different densities: (0) 10, 
(A) 16, and (m) 36 cells per field of vision (Leitz Diavert, 320X). 
Because of the mathematical representation of the 
data an exact determination of the log period is guaran- 
teed. TAU as a function of time clearly reveals the dura- 
tion of the lag and plateau phases. This approach over- 
comes the major drawback of graphical methods which 
only give a poor estimate of cell kinetics. This method 
offers universal applicability to biological investigations 
whenever growth kinetics must be monitored. Its use is 
by no way restricted to calorimetric measurement. Its 
application can also be extended to turbidimetric, fluo- 
rometric, radiochemical, etc., monitoring techniques. 
The only prerequisite is that a large number of data 
which can be digitized are available. 
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